19:08:40 EDT Sat 19 Oct 2019
Enter Symbol
or Name
USA
CA



Login ID:
Password:
Save

News for U:VNDA from 2018-10-19 to 2019-10-18 - 119 items News ReleasesIn The NewsOther
DateSymPriceTypeHeadline
2019-10-16 16:01VNDANews ReleaseVanda Applauds White House Issuance of Executive Orders Requiring Federal Agencies to be Transparent in Policymaking and Enforcement
2019-09-11 17:20VNDANews ReleaseVanda Pharmaceuticals Applauds the EPA's Landmark Commitment to Eliminate Animal Testing and Urges the Food and Drug Administration to End Unnecessary and Scientifically Flawed Animal Toxicity Studies
2019-08-21 07:00VNDANews ReleaseVanda Pharmaceuticals Announces the Appointments of a Chief Corporate Affairs and Communications Officer and a Chief Marketing Officer
2019-08-19 07:00VNDANews ReleaseVanda Pharmaceuticals FDA Update for HETLIOZ ® in the Treatment of Jet Lag Disorder
2019-07-31 16:01VNDANews ReleaseVanda Pharmaceuticals Reports Second Quarter 2019 Financial Results
2019-07-29 14:19VNDANews ReleaseShareholder Alert: Robbins Arroyo LLP: Vanda Pharmaceuticals Inc. (VNDA) Sued for Misleading Investors
2019-07-22 16:01VNDANews ReleaseVanda Pharmaceuticals to Announce Second Quarter 2019 Financial Results on July 31, 2019
2019-07-22 07:00VNDANews ReleaseVanda Pharmaceuticals FDA Update for HETLIOZ ® in the Treatment of Jet Lag Disorder
2019-07-16 16:15VNDANews ReleaseTradipitant Effective in Preventing Motion Sickness
2019-07-16 15:36VNDANews ReleaseSHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces an Investigation Concerning Possible Breaches of Fiduciary Duty by Certain Officers and Directors of Vanda Pharmaceuticals Inc. – VNDA
2019-06-18 09:50VNDANews ReleaseVanda Pharmaceuticals to Present at the JMP Securities Life Sciences Conference
2019-05-31 09:45VNDANews ReleaseVanda Pharmaceuticals Announces Participation at the Jefferies 2019 Global Healthcare Conference
2019-05-22 16:01VNDANews ReleaseTradipitant in the Treatment of Gastroparesis: Vanda Presents Clinical Trial Results at DDW 2019
2019-05-01 16:01VNDANews ReleaseVanda Pharmaceuticals Reports First Quarter 2019 Financial Results
2019-04-25 10:00VNDANews ReleaseFRIDAY DEADLINE: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Vanda Pharmaceuticals Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
2019-04-24 16:30VNDANews ReleaseVanda Pharmaceuticals Appoints Phaedra Chrousos to Board of Directors
2019-04-24 16:06VNDANews ReleaseGlancy Prongay & Murray LLP Announces the Filing of a Securities Class Action on Behalf of Vanda Pharmaceuticals Inc. Investors (VNDA)
2019-04-23 17:54VNDANews ReleaseVANDA FRIDAY DEADLINE: Rosen Law Firm Reminds Vanda Pharmaceuticals Inc. Investors of Important April 26th Deadline in First-Filed Case – VNDA
2019-04-19 19:14VNDANews ReleaseGlancy Prongay & Murray Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Vanda Pharmaceuticals Inc.
2019-04-18 16:30VNDANews ReleaseVanda Pharmaceuticals to Announce First Quarter 2019 Financial Results on May 1, 2019
2019-04-18 14:06VNDANews ReleaseSHAREHOLDER ALERT: Pawar Law Group Announces a Securities Class Action Lawsuit Against Vanda Pharmaceuticals Inc. – VNDA
2019-04-18 06:30VNDANews ReleaseBragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Vanda Pharmaceuticals, Syneos, Weight Watchers, and Mattel and Encourages Investors to Contact the Firm
2019-04-17 16:12VNDANews ReleaseA Securities Class Action Has Been Filed Against Vanda; Block & Leviton LLP Encourages Shareholders to Contact the Firm
2019-04-16 18:03VNDANews ReleaseSHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims  On Behalf of Investors of Vanda Pharmaceuticals Inc. – VNDA
2019-04-15 17:44VNDANews ReleaseVNDA APRIL 26th DEADLINE: Rosen Law Firm Files Securities Class Action Lawsuit Against Vanda Pharmaceuticals Inc.; Encourages Investors With Losses In Excess of $100K to Contact the Firm – VNDA
2019-04-11 15:06VNDANews ReleaseVNDA APR 26 DEADLINE: Zhang Investor Law Reminds of Deadline in Class Action Against Vanda Pharmaceuticals Inc. – VNDA
2019-04-11 06:00VNDANews ReleaseBragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Vanda Pharmaceuticals, Syneos, Weight Watchers, and Mattel and Encourages Investors to Contact the Firm
2019-04-10 16:10VNDANews ReleaseLEAD PLAINTIFF DEADLINE ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 Investing In Vanda Pharmaceuticals, Inc. To Contact The Firm
2019-04-09 17:57VNDANews ReleaseLEAD PLAINTIFF DEADLINE ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 Investing In Vanda Pharmaceuticals, Inc. To Contact The Firm
2019-04-07 09:00VNDANews ReleaseSHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Vanda Pharmaceuticals Inc. – VNDA
2019-04-06 13:10VNDANews ReleaseINVESTOR ALERT: Kirby McInerney LLP Reminds Investors That a Class Action Lawsuit Has Been Filed Against Vanda Pharmaceuticals Inc. and Encourages Investors to Contact the Firm Before April 26
2019-04-04 16:00VNDANews ReleaseSafirstein Metcalf LLP Announces That A Class Action Has Been Filed Against Vanda Pharmaceuticals Inc. - VNDA
2019-04-04 06:00VNDANews ReleaseBragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Vanda Pharmaceuticals, Syneos, Weight Watchers, and Mattel and Encourages Investors to Contact the Firm
2019-04-03 16:34VNDANews ReleaseHagens Berman Reminds Vanda Pharmaceuticals (VNDA) Investors of April 26, 2019 Lead Plaintiff Deadline and Encourages Investors to Contact the Firm
2019-04-03 14:58VNDANews ReleaseLEAD PLAINTIFF DEADLINE ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 Investing In Vanda Pharmaceuticals, Inc. To Contact The Firm
2019-04-02 17:46VNDANews ReleaseVNDA APRIL 26th DEADLINE: Rosen Law Firm Reminds Vanda Pharmaceuticals Inc. Investors of Important Deadline in First-Filed Case – VNDA
2019-04-02 17:33VNDANews ReleaseLEAD PLAINTIFF DEADLINE ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 Investing In Vanda Pharmaceuticals, Inc. To Contact The Firm
2019-03-29 13:39VNDANews ReleaseDeadline Reminder: The Law Offices of Howard G. Smith Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Vanda Pharmaceuticals Inc.
2019-03-29 10:00VNDANews ReleaseGlancy Prongay & Murray LLP Announces the Filing of a Securities Class Action on Behalf of Vanda Pharmaceuticals Inc. Investors (VNDA)
2019-03-28 18:50VNDANews ReleaseINVESTOR ALERT: Law Offices of Howard G. Smith Announces the Filing of a Securities Class Action on Behalf of Vanda Pharmaceuticals Inc. Investors
2019-03-28 16:25VNDANews ReleaseSHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Vanda Pharmaceuticals Inc. – VNDA
2019-03-28 09:30VNDANews ReleaseHagens Berman Reminds Vanda Pharmaceuticals (NASDAQ: VNDA) Investors of the April 26, 2019 Lead Plaintiff Deadline and Unsealed Government Lawsuit
2019-03-28 07:00VNDANews ReleaseBragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Vanda Pharmaceuticals, AVEO Pharmaceuticals, Stamps.com, and Syneos and Encourages Investors to Contact the Firm
2019-03-27 18:25VNDANews ReleaseLEAD PLAINTIFF DEADLINE ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 Investing In Vanda Pharmaceuticals, Inc. To Contact The Firm
2019-03-26 14:58VNDANews ReleaseVNDA DEADLINE: Zhang Investor Law Reminds of Deadline in Class Action Against Vanda Pharmaceuticals Inc. – VNDA
2019-03-21 19:26VNDANews ReleaseSHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Vanda Pharmaceuticals Inc. – VNDA
2019-03-20 20:47VNDANews ReleaseSHAREHOLDER ALERT: Pawar Law Group Announces a Securities Class Action Lawsuit Against Vanda Pharmaceuticals Inc. – VNDA
2019-03-20 15:53VNDANews ReleaseCLASS ACTION ALERT: Brower Piven Notifies Investors of Class Action Lawsuit And Encourages Those Who Have Significant Losses From Investment In Vanda Pharmaceuticals Inc. (Nasdaq: VNDA) To Contact Brower Piven Before The Lead Plaintiff Deadline
2019-03-19 16:29VNDANews ReleaseLEAD PLAINTIFF DEADLINE ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 Investing In Vanda Pharmaceuticals, Inc. To Contact The Firm
2019-03-19 11:07VNDANews ReleaseApril 26th Vanda (VNDA) Deadline: Bernstein Liebhard LLP Reminds Investors of the Important Upcoming Deadline in the Shareholder Class Action Lawsuit Against Vanda Pharmaceuticals Inc. – VNDA
2019-03-15 19:28VNDANews ReleaseSHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Vanda Pharmaceuticals Inc. – VNDA
2019-03-14 15:00VNDANews ReleaseVanda Pharmaceuticals Inc. (VNDA)  Bronstein, Gewirtz & Grossman, LLC Class Action Update and Deadline: April 26, 2019
2019-03-13 17:55VNDANews ReleaseVNDA APRIL 26th DEADLINE ALERT: Rosen Law Firm Reminds Vanda Pharmaceuticals Inc. Investors of Important Deadline in First-Filed Case; Encourages Investors With Losses in Excess of $100K to Contact the Firm – VNDA
2019-03-11 15:39VNDANews ReleaseVanda (VNDA) Class Action Lawsuit: Bernstein Liebhard LLP Announces a Securities Class Action Lawsuit Against Vanda Pharmaceuticals Inc. – VNDA
2019-03-11 11:39VNDANews ReleaseVanda (VNDA) Class Action Lawsuit: Bernstein Liebhard LLP Announces a Securities Class Action Lawsuit Against Vanda Pharmaceuticals Inc. – VNDA
2019-03-08 12:00VNDANews ReleaseVanda Pharmaceuticals Inc. (VNDA) Bronstein, Gewirtz & Grossman, LLC Class Action Update and Deadline: April 26, 2019
2019-03-07 21:00VNDANews ReleaseSHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims  On Behalf of Investors of Vanda Pharmaceuticals Inc. – VNDA
2019-03-07 19:39VNDANews ReleaseGlancy Prongay & Murray LLP Announces the Filing of a Securities Class Action on Behalf of Vanda Pharmaceuticals Inc. Investors (VNDA)
2019-03-07 18:39VNDANews ReleaseVNDA LAWSUIT ALERT: Rosen Law Firm Files Securities Class Action Lawsuit Against Vanda Pharmaceuticals Inc. - VNDA
2019-03-07 16:39VNDANews ReleaseVanda (VNDA) Class Action Lawsuit: Bernstein Liebhard LLP Announces A Securities Class Action Lawsuit Against Vanda Pharmaceuticals Inc. – VNDA
2019-03-07 16:02VNDANews ReleaseVNDA CLASS ACTION ALERT: Hagens Berman Alerts Vanda Pharmaceuticals (VNDA) Investors to Securities Class Action and April 26, 2019 Lead Plaintiff Deadline
2019-03-07 16:01VNDANews ReleaseVanda Pharmaceuticals to Present at the Cowen and Company 39th Annual Health Care Conference
2019-03-07 07:57VNDANews Release(VNDA) Alert: Johnson Fistel Reminds Investors of Deadline in the Class Action Lawsuit Against Vanda Pharmaceuticals Inc.
2019-03-06 20:47VNDANews ReleaseINVESTOR ALERT: Law Offices of Howard G. Smith Announces the Filing of a Securities Class Action on Behalf of Vanda Pharmaceuticals Inc. Investors
2019-03-05 19:31VNDANews ReleaseINVESTOR ALERT: Law Offices of Howard G. Smith Announces the Filing of a Securities Class Action on Behalf of Vanda Pharmaceuticals Inc. Investors
2019-03-05 14:52VNDANews ReleaseIMPORTANT INVESTOR NOTICE: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Vanda Pharmaceuticals Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
2019-03-05 08:20VNDANews ReleaseAnalysis: Positioning to Benefit within IHS Markit, PRA Group, Acacia Communications, Vanda Pharmaceuticals, Gran Tierra Energy, and Kornit Digital — Research Highlights Growth, Revenue, and Consolidated Results
2019-03-04 18:41VNDANews ReleaseGlancy Prongay & Murray LLP Announces Investigation on Behalf of Vanda Pharmaceuticals Inc. Investors
2019-03-04 11:33VNDANews ReleaseCLASS ACTION UPDATE for DPLO and VNDA: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders
2019-03-04 10:59VNDANews ReleaseIMPORTANT INVESTOR REMINDER: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Vanda Pharmaceuticals Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
2019-03-03 18:20VNDANews ReleaseBragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Diplomat Pharmacy, Vanda Pharmaceuticals, and AVEO Pharmaceuticals and Encourages Investors to Contact the Firm
2019-03-03 10:02VNDANews ReleaseVNDA INVESTOR ALERT: Rosen Law Firm Reminds Vanda Pharmaceuticals Inc. Investors of Important Deadline in First-Filed Case – VNDA
2019-03-02 07:00VNDANews ReleaseINVESTOR ALERT: Kirby McInerney LLP Announces the Filing of a Securities Class Action Lawsuit Against Vanda Pharmaceuticals Inc.
2019-03-01 17:02VNDANews ReleaseIMPORTANT INVESTOR ALERT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Vanda Pharmaceuticals Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
2019-03-01 16:05VNDANews ReleaseVANDA PHARMACEUTICALS INC. INVESTOR ALERT: Wolf Haldenstein Adler Freeman & Herz LLP announces that a securities class action lawsuit has been  filed  in  the  United States District Court  for the Eastern District of New York against  Vanda Pharmaceutica
2019-03-01 15:50VNDANews ReleaseSHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Vanda Pharmaceuticals Inc. – VNDA
2019-03-01 15:49VNDANews ReleaseSHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Vanda Pharmaceuticals Inc. – VNDA
2019-03-01 07:20VNDANews ReleaseFactors of Influence in 2019, Key Indicators and Opportunity within Vanda Pharmaceuticals, Range Resources, Fortune Brands Home & Security, Dr. Reddy's Laboratories, BWX Technologies, and K12 — New Research Emphasizes Economic Growth
2019-02-28 13:53VNDANews ReleaseCLASS ACTION ALERT: Brower Piven Notifies Investors of Class Action Lawsuit And Encourages Those Who Have Significant Losses From Investment In Vanda Pharmaceuticals Inc. (Nasdaq: VNDA) To Contact Brower Piven Before The Lead Plaintiff Deadline
2019-02-28 11:52VNDANews ReleaseRM LAW Announces Class Action Lawsuit Against Vanda Pharmaceuticals Inc.
2019-02-27 17:43VNDANews ReleaseVanda (VNDA) Class Action Lawsuit: Bernstein Liebhard LLP Announces A Securities Class Action Lawsuit Against Vanda Pharmaceuticals Inc. - VNDA
2019-02-27 07:00VNDANews ReleaseNew Research Coverage Highlights Cisco, Mattel, Celgene, Vanda Pharmaceuticals, NuStar Energy, and Aon plc — Consolidated Revenues, Company Growth, and Expectations for 2019
2019-02-26 19:46VNDANews ReleaseSHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Vanda Pharmaceuticals Inc. - VNDA
2019-02-26 19:30VNDANews ReleaseGainey McKenna & Egleston Announces A Class  Action Lawsuit Has Been Filed Against Vanda Pharmaceuticals Inc. (VNDA)
2019-02-26 18:08VNDANews ReleaseRobbins Arroyo LLP: Vanda Pharmaceuticals Inc. (VNDA) Sued for Misleading Shareholders
2019-02-26 15:47VNDANews ReleaseFederman & Sherwood Announces Filing of Securities Class Action Lawsuit Against Vanda Pharmaceuticals, Inc.
2019-02-25 20:17VNDANews ReleaseBragar Eagel & Squire, P.C. Announces That a Class Action Lawsuit Has Been Filed Against Vanda Pharmaceuticals Inc. (VNDA) and Encourages VNDA Investors to Contact the Firm
2019-02-25 16:25VNDANews ReleaseEQUITY ALERT: Rosen Law Firm Files Securities Class Action Lawsuit Against Vanda Pharmaceuticals Inc. – VNDA
2019-02-21 16:43VNDANews ReleaseVANDA INVESTOR ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 Investing In Vanda Pharmaceuticals Inc. To Contact The Firm
2019-02-20 15:52VNDANews ReleaseLifshitz & Miller LLP Announces Investigation of Bristow Group Inc., Helius Medical Technologies, Inc., Nordstrom Inc., PriceSmart, Inc., Ryanair Holdings plc, Solid Biosciences Inc., and Vanda Pharmaceuticals Inc.
2019-02-20 09:52VNDANews ReleaseEQUITY ALERT: Rosen Law Firm Continues to Investigate Securities Claims Against Vanda Pharmaceuticals Inc.; Investors are Encouraged to Contact the Firm – VNDA
2019-02-20 07:40VNDANews ReleaseNew Research: Key Drivers of Growth for Arconic, Vanda Pharmaceuticals, Avaya, Sempra Energy, Forward Industries, and Alamo Group — Factors of Influence, Major Initiatives and Sustained Production
2019-02-19 11:00VNDANews ReleaseGlancy Prongay & Murray LLP Announces Investigation on Behalf of Vanda Pharmaceuticals Inc. Investors
2019-02-14 15:00VNDANews ReleaseONGOING INVESTIGATION: The Schall Law Firm Announces it is Investigating Claims Against Vanda Pharmaceuticals Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
2019-02-14 11:00VNDANews ReleaseGlancy Prongay & Murray LLP Announces Investigation on Behalf of Vanda Pharmaceuticals Inc. Investors
2019-02-13 17:10VNDANews ReleaseINVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation on Behalf of Vanda Pharmaceuticals Inc. Investors (VNDA)
2019-02-13 16:01VNDANews ReleaseVanda Pharmaceuticals Reports Fourth Quarter 2018 and Full Year 2018 Financial Results
2019-02-13 15:16VNDANews ReleaseINVESTIGATION REMINDER: The Schall Law Firm Announces it is Investigating Claims Against Vanda Pharmaceuticals Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
2019-02-13 14:37VNDANews ReleaseVanda Pharmaceuticals Inc. to Host Earnings Call
2019-02-13 13:00VNDANews ReleaseVANDA INVESTOR ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 Investing In Vanda Pharmaceuticals Inc. To Contact The Firm
2019-02-12 16:22VNDANews ReleaseINVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Vanda Pharmaceuticals Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
2019-02-12 10:41VNDANews ReleaseSHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Vanda Pharmaceuticals Inc. (VNDA)
2019-02-12 08:32VNDANews ReleaseWolf Popper LLP Announces Investigation on Behalf of Investors in Vanda Pharmaceuticals Inc.
2019-02-11 19:00VNDANews ReleaseINVESTOR ALERT: Kirby McInerney LLP Announces an Investigation of Shareholder Claims Against Vanda Pharmaceuticals Inc.
2019-02-11 17:01VNDANews ReleaseINVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation on Behalf of Vanda Pharmaceuticals Inc. Investors (VNDA)
2019-02-11 15:12VNDANews ReleaseBragar Eagel & Squire, P.C. is Investigating Vanda Pharmaceuticals Inc. (VNDA) on Behalf of Stockholders and Encourages VNDA Investors to Contact the Firm
2019-02-11 11:38VNDANews ReleaseEQUITY ALERT: Rosen Law Firm Announces Investigation of Securities Claims Against Vanda Pharmaceuticals Inc.
2019-02-11 10:50VNDANews ReleaseVanda Pharmaceuticals Inc. Investigated by Block & Leviton LLP For Violations of Federal Securities Laws
2019-02-05 17:05VNDANews ReleaseVanda Pharmaceuticals Takes a Stand Against Unnecessary Animal Research
2019-01-29 07:40VNDANews ReleaseNew Research: Key Drivers of Growth for McCormick & Company, Darden Restaurants, Vanda Pharmaceuticals, SunPower, Pretium Resources, and America's Car-Mart — Factors of Influence, Major Initiatives and Sustained Production
2019-01-25 09:30VNDANews ReleaseVanda Pharmaceuticals to Announce Fourth Quarter and Full Year 2018 Financial Results on February 13, 2019
2018-12-20 07:00VNDANews ReleaseFDA Accepts HETLIOZ ® (tasimelteon) Supplemental New Drug Application for Review in the Treatment of Jet Lag Disorder
2018-12-10 07:00VNDANews ReleaseVanda Announces Positive Pivotal Study Results for HETLIOZ ® (tasimelteon) in Patients with Smith-Magenis Syndrome
2018-12-03 06:00VNDANews ReleaseVanda Announces Positive Phase II Study Results for Tradipitant in Patients with Gastroparesis
2018-11-08 17:35VNDANews ReleaseVanda Pharmaceuticals Announces Participation at November 2018 Investor Conferences
2018-11-07 16:01VNDANews ReleaseVanda Pharmaceuticals Reports Third Quarter 2018 Financial Results
2018-11-01 09:40VNDANews ReleaseVanda Receives FDA Letter Regarding Corporate Webpage
2018-10-24 07:30VNDANews ReleaseConsolidated Research: 2018 Summary Expectations for Airgain, Vanda Pharmaceuticals, Westlake Chemical, TransEnterix, Versum Materials, and Triumph Group — Fundamental Analysis, Key Performance Indications
2018-10-22 16:30VNDANews ReleaseVanda Pharmaceuticals to Announce Third Quarter 2018 Financial Results on November 7, 2018